Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study

Journal of Psychiatric Research

Volumn 47, Issue 3, 2013, Pages 357-362

  Demirkan, Ayşe ^a   Isaacs, Aaron ^a,b   Ugocsai, Peter ^c   Liebisch, Gerhard ^c   Struchalin, Maksim ^a   Rudan, Igor ^d,e,f   Wilson, James F ^d   Pramstaller, Peter P ^g,h,i   Gyllensten, Ulf ^j   Campbell, Harry ^d   Schmitz, Gerd ^c   Oostra, Ben A ^a   van Duijn, Cornelia M ^a,b,k  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^f UNIVERSITY OF SPLIT   (Croatia)

^g University of Lubeck   (Italy)

^h General Central Hospital   (Italy)

ⁱ UNIVERSITY OF LÜBECK   (Germany)

^j UPPSALA UNIVERSITY   (Sweden)

^k Netherlands Consortium for Healthy Ageing   (Netherlands)

more..

Author keywords

Anxiety; Arachidonic acid; Depression; Lipidomics; Phospholipid

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN; TRIACYLGLYCEROL;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHOLESTEROL BLOOD LEVEL; DEPRESSION; EDUCATIONAL STATUS; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LIPIDOMICS; MALE; PRIORITY JOURNAL;

EID: 84873525686     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.11.001     Document Type: Article

References (48)

1. Almasy L., Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. American Journal of Human Genetics 1998, 62:1198-1211.
2. Aulchenko Y.S., Heutink P., Mackay I., Bertoli-Avella A.M., Pullen J., Vaessen N., et al. Linkage disequilibrium in young genetically isolated Dutch population. European Journal of Human Genetics 2004, 12:527-534.
3. Beekman A.T., Deeg D.J., Van Limbeek J., Braam A.W., De Vries M.Z., Van Tilburg W. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands. Psychological Medicine 1997, 27:231-235.
4. Bjelland I., Dahl A.A., Haug T.T., Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. Journal of Psychosomatic Research 2002, 52:69-77.
5. Brites P., Waterham H.R., Wanders R.J. Functions and biosynthesis of plasmalogens in health and disease. Biochimica et Biophysica Acta 2004, 1636:219-231.
6. Brugger B., Erben G., Sandhoff R., Wieland F.T., Lehmann W.D. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:2339-2344.
7. Chang M.C., Grange E., Rabin O., Bell J.M., Allen D.D., Rapoport S.I. Lithium decreases turnover of arachidonate in several brain phospholipids. Neuroscience Letters 1996, 220:171-174.
8. Chang M.C., Jones C.R. Chronic lithium treatment decreases brain phospholipase A2 activity. Neurochemical Research 1998, 23:887-892.
9. Chilton F.H., Fonteh A.N., Sung C.M., Hickey D.M., Torphy T.J., Mayer R.J., et al. Inhibitors of CoA-independent transacylase block the movement of arachidonate into 1-ether-linked phospholipids of human neutrophils. Biochemistry 1995, 34:5403-5410.
10. Cutler R.G., Mattson M.P. Sphingomyelin and ceramide as regulators of development and lifespan. Mechanisms of Ageing and Development 2001, 122:895-908.
11. Demirkan A., van Duijn C.M., Ugocsai P., Isaacs A., Pramstaller P.P., Liebisch G., et al. Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations. PLoS Genetics 2012, 8:e1002490.
12. Engelmann B., Wiedmann M.K. Cellular phospholipid uptake: flexible paths to coregulate the functions of intracellular lipids. Biochimica et Biophysica Acta 2010, 1801:609-616.
13. Farooqui A.A. Studies on plasmalogen-selective phospholipase A2 in brain. Molecular Neurobiology 2010, 41:267-273.
14. Farooqui A.A. Lipid mediators in the neural cell nucleus: their metabolism, signaling, and association with neurological disorders. Neuroscientist 2009, 15:392-407.
15. Farooqui A.A., Horrocks L.A. Brain phospholipases A2: a perspective on the history. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2004, 71:161-169.
16. Farooqui A.A., Horrocks L.A., Farooqui T. Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chemistry and Physics of Lipids 2000, 106:1-29.
17. Fisher R.A. Frequency distribution of the values of the correlation coefficient in samples of an indefinitely large population. Biometrika (Biometrika Trust) 1915, 10:507-521.
18. Goni F.M., Alonso A. Effects of ceramide and other simple sphingolipids on membrane lateral structure. Biochimica et Biophysica Acta 2009, 1788:169-177.
19. Guzzetta F., Tondo L., Centorrino F., Baldessarini R.J. Lithium treatment reduces suicide risk in recurrent major depressive disorder. Journal of Clinical Psychiatry 2007, 68:380-383.
20. Harlow S.D., Goldberg E.L., Comstock G.W. A longitudinal study of risk factors for depressive symptomatology in elderly widowed and married women. American Journal of Epidemiology 1991, 134:526-538.
21. Horrobin D.F. Phospholipid metabolism and depression: the possible roles of phospholipase A2 and coenzyme A-independent transacylase. Human Psychopharmacology 2001, 16:45-52.
22. Horrobin D.F., Bennett C.N. Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. Prostaglandins, Leukotrienes, and Essential Fatty Acids 1999, 60:217-234.
23. Horrocks L.A., Farooqui A.A. Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2004, 70:361-372.
24. Igarashi M., Kim H.W., Chang L., Ma K., Rapoport S.I. Dietary n-6 polyunsaturated fatty acid deprivation increases docosahexaenoic acid metabolism in rat brain. Journal of Neurochemistry 2012, 120:985-997.
25. Jenkins R.W., Canals D., Hannun Y.A. Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cellular Signalling 2009, 21:836-846.
26. Kim H.W., Rapoport S.I., Rao J.S. Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients. Molecular Psychiatry 2011, 16:419-428.
27. Kolzer M., Werth N., Sandhoff K. Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine. FEBS Letters 2004, 559:96-98.
28. Kornhuber J., Medlin A., Bleich S., Jendrossek V., Henkel A.W., Wiltfang J., et al. High activity of acid sphingomyelinase in major depression. Journal of Neural Transmission 2005, 112:1583-1590.
29. Kornhuber J., Reichel M., Tripal P., Groemer T.W., Henkel A.W., Muhle C., et al. The role of ceramide in major depressive disorder. European Archives of Psychiatry and Clinical Neuroscience 2009, 259(Suppl. 2):S199-S204.
30. Koumanov K.S., Momchilova A.B., Quinn P.J., Wolf C. Ceramides increase the activity of the secretory phospholipase A2 and alter its fatty acid specificity. Biochemical Journal 2002, 363:45-51.
31. Kuchibhatla M.N., Fillenbaum G.G., Hybels C.F., Blazer D.G. Trajectory classes of depressive symptoms in a community sample of older adults. Acta Psychiatrica Scandinavica 2012, 125(6):492-501.
32. Liebisch G., Drobnik W., Lieser B., Schmitz G. High-throughput quantification of lysophosphatidylcholine by electrospray ionization tandem mass spectrometry. Clinical Chemistry 2002, 48:2217-2224.
33. Liebisch G., Lieser B., Rathenberg J., Drobnik W., Schmitz G. High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm. Biochimica et Biophysica Acta 2004, 1686:108-117.
34. Lin P.Y., Huang S.Y., Su K.P. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biological Psychiatry 2010, 68:140-147.
35. Liu F., Kirichenko A., Axenovich T.I., van Duijn C.M., Aulchenko Y.S. An approach for cutting large and complex pedigrees for linkage analysis. European Journal of Human Genetics 2008, 16:854-860.
36. Mitchell R.W., Hatch G.M. Fatty acid transport into the brain: of fatty acid fables and lipid tails. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2011, 85:293-302.
37. Morrel P., Toews A.D. Biochemistry of lipids. Handbook of clinical neurology 1993, 33-49. Elsevier, Amsterdam. M. H.W. (Ed.).
38. Radloff The CES-D scale: a self report depression scale for research in the general population. Applied Psychological Measurement 1977, 3:385-401.
39. Spector A.A. Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain. Journal of Molecular Neuroscience 2001, 16:159-165. discussion 215-221.
40. Su K.P., Shen W.W., Huang S.Y. Effects of polyunsaturated fatty acids on psychiatric disorders. American Journal of Clinical Nutrition 2000, 72:1241.
41. Tettamanti G. Ganglioside/glycosphingolipid turnover: new concepts. Glycoconjugate Journal 2004, 20:301-317.
42. Tiemeier H., van Tuijl H.R., Hofman A., Kiliaan A.J., Breteler M.M. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. American Journal of Clinical Nutrition 2003, 78:40-46.
43. van Blitterswijk W.J., van der Luit A.H., Veldman R.J., Verheij M., Borst J. Ceramide: second messenger or modulator of membrane structure and dynamics?. Biochemical Journal 2003, 369:199-211.
44. Watkins P.A., Hamilton J.A., Leaf A., Spector A.A., Moore S.A., Anderson R.E., et al. Brain uptake and utilization of fatty acids: applications to peroxisomal biogenesis diseases. Journal of Molecular Neuroscience 2001, 16:87-92. discussion 151-157.
45. Winkler J.D., Bolognese B.J., Roshak A.K., Sung C.M., Marshall L.A. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes. Biochimica et Biophysica Acta 1997, 1346:173-184.
46. Zemski Berry K.A., Murphy R.C. Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids. Journal of the American Society for Mass Spectrometry 2004, 15:1499-1508.
47. Zhang Y., Li X., Becker K.A., Gulbins E. Ceramide-enriched membrane domains-structure and function. Biochimica et Biophysica Acta 2009, 1788:178-183.
48. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983, 67:361-370.